Accendra Health, Inc.

NYSE:ACH

Medical - Distribution

Healthcare
$0.71 +3.64%

+$0.12 today

Market cap
$54.22M
Beta
1.63
P/E (TTM)
-0.2
EPS (TTM)
-$14.11
52W Low $1.84High $9.55

Volume 1.41M

Average 0.83M

ACH Total Debt

Short-term and long-term borrowings combined.

Accendra Health, Inc.NYSE: ACH

Total Debt · Q1 FY2026 · quarter ended Mar 2026

Total debt falls 4.4% from a year ago

Total debt stood at $2.17B at the end of Q1 FY2026, down 4.4% from a year earlier and down 2.8% from the prior quarter. Over 3 fiscal years it compounded at -7.2% a year.

Context

  • Total debt amounted to 89.8% of total assets at the end of Q1 FY2026, up 43.1 pp from a year earlier.
  • Total debt increased in 1 of the last 3 fiscal years.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -4.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.17B-2.8% QoQ
Last fiscal yearDec 2025
$2.23B+4.4% YoY
Year agoMar 2025
$2.27B-4.4% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.4%——
1 year+4.4%——
3-year CAGR-7.2%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
2.23B USD
Year-over-year change
+4.4%
4-year CAGR
+18.0%

Total Debt vs competitors

How ACH compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -4.4% is the 6th highest of 11, against a peer median of -4.2%.
  • Total debt amounts to 89.8% of total assets for ACH, versus a peer median of 22.7%.
ACH Competitors
Total Debt for ACH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ACHAccendra Health, Inc.Mar 2026$2.17B USD-4.4%-7.2%89.8%
CGCCanopy Growth CorporationMar 2026CA$278.71M CAD-20.0%-38.7%24.9%
OMOutset Medical, Inc.Mar 2026$101.61M USD+3.5%-0.6%40.7%
ALLOAllogene Therapeutics, Inc.Mar 2026$81.05M USD-0.3%-6.3%20.5%
EDITEditas Medicine, Inc.Mar 2026$71.97M USD+131.2%+20.4%48.2%
CVRXCVRx, Inc.Mar 2026$59.4M USD+17.8%+92.8%59.6%
SGHTSight Sciences, Inc.Mar 2026$41.76M USD+3.2%+5.2%38.1%
CABACabaletta Bio, Inc.Mar 2026$26.45M USD-8.1%+74.1%17.9%
HITIHigh Tide Inc.Apr 2026CA$18.21M CAD-71.3%+28.9%5.2%
BIOABioAge Labs, Inc.Mar 2026$4.03M USD-60.9%+31.1%1.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$1.99M USD-20.1%+45.7%1.0%
Peer median (excluding ACH) —-4.2%+24.7%22.7%

Competitors are the stored peer set for ACH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents55.71M69.47M243.04M49.38M281.99M
Short-term Investments00000
Net Receivables681.56M763.5M598.26M690.24M95.91M
Inventory1.5B1.33B1.11B1.13B74.44M
Other Current Assets88.56M128.64M150.89M149.52M95.54M
Total Current Assets2.32B2.3B2.1B2.02B547.87M
Property, Plant & Equipment (Net)511.24M858.93M840.51M864.97M365.26M
Goodwill390.19M1.64B1.64B1.33B1.23B
Intangible Assets243.75M483.74M361.84M296.73M136.47M
Long-term Investments16.32M15.46M8.45M6.11M1.34M
Tax Assets00(8.45M)00
Other Non-current Assets53.25M96.26M149.35M134.05M172.69M
Total Non-current Assets1.21B3.09B2.99B2.63B1.9B
Total Assets3.54B5.39B5.09B4.66B2.45B
Account Payables1B1.15B1.17B1.25B363.57M
Short-term Debt43.85M15.38M204.08M40M293.27M
Tax Payables00000
Deferred Revenue00116.4M00
Other Current Liabilities182.35M227.44M191.66M425.54M220.81M
Total Current Liabilities1.34B1.57B1.89B1.87B947.08M
Long-term Debt936.23M2.47B1.88B1.8B1.87B
Deferred Tax Liabilities35.31M60.83M41.65M22.46M0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities108.94M114.94M122.59M100.13M25.15M
Total Non-current Liabilities1.25B2.87B2.28B2.22B1.97B
Total Liabilities2.6B4.44B4.17B4.09B2.91B
Common Stock150.87M152.56M153.09M154.4M152.78M
Retained Earnings387.62M410.01M368.71M6.02M(1.08B)
Accumulated OCI(40.59M)(35.85M)(31.82M)(49.34M)(885K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity938.5M945.6M924.17M565.23M(460.98M)
Total Debt1.15B2.79B2.41B2.14B2.23B
Net Debt1.1B2.72B2.16B2.09B1.95B

Accendra Health, Inc.

NYSE:ACH

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.